** Shares of medical device firm Alphatec Holdings ATEC.O down 0.4% at $11.68 on Weds after securing capital raise to refinance near-term convertible bonds (CBs)
** Spinal surgery imaging provider late Tues announced pricing $350 mln 0.75% 5-yr convertible bonds
** Deal size increased from $300 mln
** Initial conversion price of $15.54 represents 32.5% premium to stock's last close, while capped call price of $23.46 is double Tuesday's last sale
** Co plans to use $36.7 mln of net proceeds to pay for capped calls, $268.4 mln to repurchase $253 mln of its outstanding 0.75% CBs due 2026
** Carlsbad, California-based firm has ~$1.7 bln market cap, per LSEG data
** Last Thurs, ATEC shares rose nearly 10% after co reported Q4 rev of $177 mln, up 28% y/y, topping consensus est. of ~$172.5 mln, and reaffirmed 2025 rev guidance of ~$732 mln
** With move on the session, stock up ~27% YTD following 39% drop in 2024
** Of 12 analysts covering ATEC, recommendation breakdown is 11 "strong buy" or "buy" and 1 "hold"; median PT of $18.92 implies >60% upside to current levels
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。